Max Robotics — Global Service Robot Directory + US Certification

About

M. Hassan Murad is a leading figure in evidence-based medicine and surgical outcomes research, with a particular focus on comparative effectiveness in oncology. His work systematically evaluates the risks and benefits of surgical approaches, especially in gynecologic and urologic cancers. A landmark contribution is his 2015 meta-analysis on robotic radical hysterectomy for early-stage cervical cancer, which has garnered 181 citations and helped shape clinical guidelines by rigorously assessing the safety and efficacy of minimally invasive techniques. He has also produced highly influential work on nephrectomy, including a 2012 comparative effectiveness study (70 citations) that informed the debate between partial and radical nephrectomy for localized renal tumors. More recently, his 2022 cohort study on minimally invasive versus open surgery for high-risk endometrial cancer (18 citations) addresses a critical gap in the literature for this patient population. Beyond these specific papers, Murad is widely recognized for his methodological expertise in systematic reviews and meta-analyses, serving as a director of evidence-based practice centers and contributing to the GRADE approach. His research consistently provides the high-quality evidence needed to guide surgical decision-making and improve patient outcomes.